Xenon Pharmaceuticals Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 7.5M | 0 | 0 | 0 |
| Cost of Goods Sold | 0 | 611K | 77.1M | 632K | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | -611K | -77.1M | -632K | 7.5M | 0 | 0 | 0 |
| R&D Expenses | 88.5M | 87.7M | 77.1M | 75.0M | 61.2M | 59.5M | 57.0M | 49.7M |
| Operating Expenses | 112.3M | 109.2M | 19.3M | 93.6M | 80.2M | 77.5M | 73.7M | 69.1M |
| Operating Income | -112.3M | -109.8M | -96.3M | -94.2M | -72.7M | -77.5M | -73.7M | -69.1M |
| Other Income / Gains | 7.5M | 5.0M | 6.1M | 8.9M | 8.1M | 7.9M | 10.6M | 10.8M |
| Net Income | -102.3M | -105.3M | -90.9M | -84.7M | -65.0M | -65.7M | -62.8M | -57.9M |
| EPS (Diluted) | -1.17 | -1.31 | -1.15 | -1.07 | -0.83 | -0.84 | -0.81 | -0.75 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 1.00 | 0 | 0 | 0 |
| General And Administrative Expenses | 23.8M | 22.1M | 19.3M | 19.2M | 19.0M | 18.0M | 16.7M | 19.4M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 23.8M | 22.1M | 19.3M | 19.2M | 19.0M | 18.0M | 16.7M | 19.4M |
| Other Expenses | 0 | -611K | -77.1M | -632K | 0 | 0 | 0 | 0 |
| Cost And Expenses | 112.3M | 109.8M | 96.3M | 94.2M | 80.2M | 77.5M | 73.7M | 69.1M |
| Interest Income | 6.9M | 6.2M | 6.2M | 7.2M | 8.1M | 9.4M | 10.3M | 10.8M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 587K | 611K | 641K | 632K | 659K | 633K | 700K | 641K |
| Ebitda | -111.7M | -104.1M | -89.6M | -93.6M | -72.1M | -76.8M | -73.0M | -68.5M |
| Ebitdaratio | 0 | 0 | 0 | 0 | -9.611 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | -9.698 | 0 | 0 | 0 |
| Income Before Tax | -104.9M | -104.7M | -90.2M | -85.3M | -64.6M | -69.5M | -63.1M | -58.3M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | -8.616 | 0 | 0 | 0 |
| Income Tax Expense | -2.6M | 538K | 677K | -626K | 427K | -3.8M | -320K | -333K |
| Net Income Ratio | 0 | 0 | 0 | 0 | -8.673 | 0 | 0 | 0 |
| Epsdiluted | -1.17 | -1.31 | -1.15 | -1.07 | -0.83 | -0.84 | -0.81 | -0.75 |
| Weighted Average Shs Out | 87.3M | 79.3M | 79.2M | 79.0M | 78.7M | 78.4M | 77.9M | 77.7M |
| Weighted Average Shs Out Dil | 87.3M | 79.3M | 79.2M | 79.0M | 78.7M | 78.4M | 77.9M | 77.7M |